Pancreatic Cancer Research

ResearcherSpanish National Cancer Research CentreActive in the last 2 years

Mark Kalisz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8770-2798; OpenAlex author ID A5101580094. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Distinct gene expression mechanisms in classical and basal PDAC subtypes. First author DOI 10.1136/gutjnl-2024-334691↗
  2. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer. Co-author DOI 10.15252/embj.2019102808↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Irene Felipe‐Abrio · 1 shared paper, 2025 · strength 0.54
  2. Lena Häberle · 1 shared paper, 2020 · strength 0.09
  3. Sami Alexander Safi · 1 shared paper, 2020 · strength 0.09
  4. Wolfram Trudo Knoefel · 1 shared paper, 2020 · strength 0.09
  5. Iréne Esposito · 1 shared paper, 2020 · strength 0.09
  6. Eva Cristina Vaquero · 1 shared paper, 2020 · strength 0.09
  7. Jorge P. Ferrer · 1 shared paper, 2020 · strength 0.09
  8. Francisco X. Real · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.